Annexon (ANNX) stock
Market cap $802M
After hours. Prices 16 minutes old, as of 7:24 PM ET. Members see real‑time prices.
This page shows 1 of ANNX's 12 score lines and 4 of its 14 traits.You've seen your 3 free stocks for today. Members see every stock ranked, every line and trait on each, and real‑time prices.
Why it's down
Down 26% in 3 months, 23% under its 50-day average.
Its industry held up: the 73 other stocks in it rose a median 2% over the same 3 months.
−2Long-term trend below a falling 200-day, down over two years
4 more things pulling ANNX's score down, for members
What's next
Reports around Nov 9, before the open
After its last 4 reports it closed +3.6% on average, higher 2 of 4 times.
What would turn ANNX's score around: 8 things, for members
7 days free. No card. Then $29 a month.
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.
Nothing is firing on ANNX right now
One trait per group is shown. There are 14, and VOL and VDU cannot both fire, so 13 is the most at once.
How ANNX ranks in Pharma
ANNX is #71 of 74 by Quality Score. The top three are shown with their scores, and the rest by name.
- 1
ABBVAbbVie8/1320
- 2
LLYEli Lilly7/1318
- 3
PFEPfizer8/1317
CRONCronos GroupOpen for its score
JNJJohnson & JohnsonOpen for its score
- 71
ANNXAnnexon0/13-6
When does ANNX report, and what happens after?
Reports in about 6 weeks, around Nov 9, 2026, before open. An estimate until the company confirms the date in an 8‑K.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 12, 2026before open | before open | -5.2% | -0.2% | -1.1% |
| May 7, 2026after close | after close | +1.7% | +3.1% | -2.7% |
| Mar 30, 2026after close | after close | +13.7% | +11.7% | +20.8% |
| Nov 10, 2025after close | after close | -1.0% | -0.3% | +1.3% |
The gap is the next open against the close before the report; the reaction is where that session closed. ANNX closed higher after 2 of its last 4. Past behavior, not a forecast.
Report dates and past reactions come from sessions that have already closed, so none of these figures move.
Who is trading ANNX
Insiders
2 insiders bought $3.4M across 2 filings in the last 6 months. No open‑market sales on record. The newest:
An insider has two business days to file a Form 4, so the trade is already days old when it becomes public. Shown as filed, with no delay.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of ANNX's score, with the points and the reason
- All 14 traits on ANNX and on all 2,961 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on ANNX
What a filing on ANNX would have sent. Alerts are optional.
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week traits rest on real history. Options flow is not part of the product.
What does it cost?
One plan with everything in it: $29 a month, $69 for three months, or $249 a year. You pick the billing period when the trial ends, and payments go through Stripe, so Breakaway never sees your card.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.
The price, the score, the traits, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.